ArticleScientific reports2020

SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells.

Nourhan Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.